Saturday, May 18, 2024

GET OUR FREE E-NEWSLETTER

“You may choose to look the other way, but you can never say again that you did not know.”

— William Wilberforce

Search

U.S. Stockpiles Two Bird Flu Vaccines

bird flu vaccine

U.S. government health officials announced earlier this month that two bird flu vaccines are being stockpiled and will be available for shipment within weeks. They said that the bird flu stockpiling is part of their emergency preparations in the event the H5N1 virus, which now primarily infects wild birds, chickens and sometimes cows and other […]

Bird Flu Outbreaks & the WHO/IHR Pandemic Treaty Push

next pandemic

Even as U.S. health agencies and the United Nations World Health Organization (WHO) are being heavily criticized for their botched response to the COVID-19 pandemic,1 2 3 WHO officials are ramping up pressure on all nations to sign a WHO pandemic treaty and amendments to the WHO’s International Health Regulations (IHR), which will give them […]

RSV Vaccines for Senior Adults Linked to Guillain-Barré Syndrome

holding vial of RSV vaccine

On Feb. 29, 2024, the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) presented a preliminary analysis that showed that 23 adults over the age of 65 who received a respiratory syncytial virus (RSV) vaccine developed Guillain-Barré syndrome (GBS).1 When a person develops GBS, including after an infection or […]

Influenza Vaccines Only 42 Percent Effective in Adults This Year

doubting man

The influenza vaccines currently being administered in the United States are estimated by the U.S. Centers for Disease Control and Prevention (CDC) to be 42 percent effective in adults. This is an interim estimate for the 2023-2024 “flu season” published in the agency’s Morbidity and Mortality Weekly Report (MMWR) on Feb. 29, 2024.1 2 3 […]

Novel mRNA Lyme Shots Could Be Released in 2025

test tube and tick

Two novel messenger RNA (mRNA) shots for Lyme disease currently in late-stage clinical trials could hit the market as early as 2025, Moderna announced earlier this year. Also in the race to develop the first-ever mRNA product to prevent Lyme disease are Pfizer and Austria-based Valneva, which entered into a collaborative agreement in April 2020 […]

Search in Site

To search in site, type your keyword and hit enter

Search